News About: Pharm. Industry
Korea’s ethical market for outpatients in January tops 726 billion won
The domestic ethical market for outpatients in January accounted for 726 billion won, showing a 15.4-percent decrease over the same period of last year and reflecting the government-led price cuts of drugs last April,...
Korea’s ethical markets getting heated
Competition is about to heat up in the domestic ethical drug markets, as Gilead Sciences’ Viread (tenofovir), Boehringer Ingelheim’s Trajenta (linagliptin) and AstraZeneca’s Brilinta (tigagrelor) are expanding their s...
Seoulin Bioscience forges strategic tie-up with Institut Pasteur Korea
SeouLin Bioscience, a Korean company specialized in wholesale trade of biotech products, said Monday that it has forged a strategic alliance with Institut Pasteur Korea (IPK) in an effort to supply IPK’s genome-wide s...
Lilly Korea launches Cialis 5 mg for 2-week once daily useLilly Korea said Monday it has launched a package program of Cialis 5 mg (tadalafil) for once daily use over two weeks to treat erectile dysfunction (ED).
When Cialis for onc...
|
Green Cross’s Hunterase gets orphan drug designation from US FDA
Green Cross Corp. said Monday its new drug Hunterase has been recently designated as orphan drug by the U.S. Food and Drug Administration.
The company plans to file the New Drug Application (NDA) for Hunterase with...
Drug firms boosting R&D spending
Domestic pharmaceutical firms have been spending more on research and development (R&D) projects to strengthen their technology leadership, industry data showed recently.
According to the Korea Health Industry Deve...
President-elect urged to back pharmaceutical industry
Despite the government's plan to provide tax cut to research-oriented domestic pharmaceutical companies as part of follow-up measures to the free trade agreement (FTA) signed with the United States, experts suggest th...
Pharmaceutical firms struggle to stay afloat
The government’s forced price cuts for drugs and other medical products covered by National Health Insurance in April last year has dealt a blow to local small- and medium-sized pharmaceutical firms.
To cope with a...
Korea expected to be global leader for Biosimilar by 2020: Frost & Sullivan
With Korea introducing a regulatory pathway for manufacturing biologics in 2009, the government has raised its stakes in the biosimilars market. It is providing both financial and institutional support to help the mar...
AminoLogics to export D-Serine to Japan
A Korean pharmaceutical company, AminoLogics, yesterday said it has signed an agreement with Sam-Oh Pharm, a Korean agent of Kyowa Hakko Bio in Japan, to export its chiral unnatural amino acid D-Serine to Japan.
In...
